Search

everythinglearnresearchcommunity

for

Search:↓

Old drugs like finasteride and spironolactone are being successfully used for hair loss and skin conditions, and many other drugs show promise for new uses in dermatology.

The document concludes that various dermatological treatments and drugs can cause skin reactions and side effects.

The document explains hair and nail biology, common hair loss conditions and treatments, oral and genital skin diseases, and the risks and treatments associated with squamous cell carcinoma.

PCOS is a common hormonal disorder with symptoms like irregular periods and excess hair growth, managed with lifestyle changes and medications.

Lichen Planopilaris is a hair loss condition best treated early with various medications, including hydroxychloroquine, to prevent permanent baldness.

New factors in female hair loss include genetics, hormones, stress, and inflammation; future treatments should also focus on these areas and consider the patient's emotional well-being.

Use the least toxic, most specific treatments for skin diseases, considering side effects and individual patient needs.

New skin treatments in 1987-1988 showed effectiveness for various conditions, but some had side effects or risks.

Children's skin diseases need special care and treatment.

No link between hair loss and blood groups or Rhesus factor.

Estrogens can improve skin aging but carry risks; more research is needed on safer treatments.

Hormones significantly affect hair and oil gland function in the skin, and more research is needed on skin-related hormone disorders.

Estrogens and SERMs can help with skin aging, but their safety and effectiveness need more research.

Syphilis has a wide range of symptoms that can look like other diseases, and if not treated, it can progress to a more serious stage, especially in HIV-positive patients.

Madarosis is the loss of eyelashes and eyebrows due to various health issues and requires thorough examination to diagnose and treat the underlying cause.

The document concludes that treating tough skin disease in lupus involves sun protection, steroids, antimalarials, and various other therapies chosen based on individual risks and benefits.

Spironolactone, a heart and liver drug, has new uses including cancer treatment, viral infection prevention, and skin condition improvement.

Male pattern baldness involves hormone-related hair thinning, shorter hair, and inflammation.

Different treatments for alopecia areata have unpredictable results and varying success rates.

Adenosine helps grow thicker hair in Japanese men with hair loss.

Transfollicular drug delivery is promising but needs more research to improve and understand it better.

A woman with HIV had a severe skin condition that improved with antiretroviral therapy.

Using methods like lasers and microneedling with drugs can improve hair regrowth for alopecia, but more research is needed on safety and best practices.

Baldness in men with prostate cancer is linked to higher levels of certain sex hormones, but chest hair density is not.

The document concludes that periocular hair disorders have various causes and treatments, and proper evaluation by specialists is important for management and prognosis.

Skin doctors should know about skin and kidney disease links to prevent serious kidney problems.

Microsponges delivery system is a safe, versatile method for controlled drug release in various treatments.

Pharmacists should interpret lab data and perform physical exams to improve patient care.

The review suggests limited treatments for common hair loss conditions, with potential for future improvements.

Transplant patients on immunosuppressive medications have a higher risk of skin cancer, and managing this involves balancing medication with cancer risk.